Heat Biologics

+$0.09 (+3.96%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch Heat Biologics and buy or sell other stocks, options, and ETFs commission-free!

About HTBX

NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.

CEO
Jeff A. Wolf, MBA
Employees
49
Headquarters
Morrisville, North Carolina
Founded
2008

HTBX Key Statistics

Market cap
60.53M
Price-Earnings ratio
—
Dividend yield
—
Average volume
116.02K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$10.85
52 Week low
$1.60

HTBX Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure